Synthesis, Structure−Activity Relationships, and Mechanism of Drug Resistance of d- and l-β-3‘-Fluoro-2‘,3‘-unsaturated-4‘-thionucleosides as Anti-HIV Agents

Journal of Medicinal Chemistry
2004.0

Abstract

Various D- and L-2',3'-unsaturated 3'-fluoro-4'-thionucleosides (D- and L-3'F-4'Sd4Ns) were synthesized for the studies of structure-activity relationships. The synthesized D-2',3'-unsaturated 3'-fluoro-4'-thionucleosides did not show any significant antiviral activity against HIV-1, while unnatural L-nucleosides such as cytosine 34 (EC(50) = 0.13 microM; EC(90) = 1.7 microM) and 5-fluorocytosine 35 (EC(50) = 0.031 microM; EC(90) = 0.35 microM) derivatives exhibited potent anti-HIV activity without significant toxicity. Molecular modeling study shows that the 3'-fluorine atom of the d-2',3'-unsaturated cytidine triphosphate (D-3'F-4'Sd4CTP) experiences unfavorable electrostatic interaction with its own triphosphate moiety, resulting in the decreased binding affinity to wild-type HIV-1 reverse transcriptase (RT), which may be one of the reasons for the insensitivity of HIV-1 RT to these compounds. On the other hand, L-3'F-4'Sd4CTP binds to the active site of wild-type HIV-1 RT without steric hindrance and there is a possible hydrogen bonding between the 3'-fluorine atom and Asp185, which correlates with its potent anti-HIV activity. However, L-3'F-4'Sd4C 34 and L-3'F-4'Sd4FC 35 showed high cross-resistance to 3TC-resistant mutant (M184V) RT. Like other unnatural L-nucleosides, the unfavorable steric hindrance of the sugar moiety of L-3'F-4'Sd4CTP with the side chain of Val184 explains its significant cross-resistance to the M184V mutant.

Knowledge Graph

Similar Paper

Synthesis, Structure−Activity Relationships, and Mechanism of Drug Resistance of <scp>d</scp>- and <scp>l</scp>-β-3‘-Fluoro-2‘,3‘-unsaturated-4‘-thionucleosides as Anti-HIV Agents
Journal of Medicinal Chemistry 2004.0
Synthesis, Anti-HIV Activity, and Molecular Mechanism of Drug Resistance of <scp>l</scp>-2‘,3‘-Didehydro-2‘,3‘-dideoxy-2‘-fluoro-4‘-thionucleosides
Journal of Medicinal Chemistry 2003.0
Synthesis, Structure−Activity Relationships, and Drug Resistance of β-<scp>d</scp>-3‘-Fluoro-2‘,3‘-Unsaturated Nucleosides as Anti-HIV Agents
Journal of Medicinal Chemistry 2004.0
<scp>l</scp>-2‘,3‘-Didehydro-2‘,3‘-dideoxy-3‘-fluoronucleosides:  Synthesis, Anti-HIV Activity, Chemical and Enzymatic Stability, and Mechanism of Resistance
Journal of Medicinal Chemistry 2003.0
Stereoselective Synthesis and Antiviral Activity of <scp>d</scp>-2‘,3‘-Didehydro-2‘,3‘-dideoxy-2‘-fluoro-4‘-thionucleosides
Journal of Medicinal Chemistry 2002.0
Synthesis, Antiviral Activity, and Mechanism of Drug Resistance of <scp>d</scp>- and <scp>l</scp>-2‘,3‘-Didehydro-2‘,3‘-dideoxy-2‘-fluorocarbocyclic Nucleosides
Journal of Medicinal Chemistry 2005.0
Structure−Activity Relationships of 2‘-Fluoro-2‘,3‘-unsaturated <scp>d</scp>-Nucleosides as Anti-HIV-1 Agents
Journal of Medicinal Chemistry 2002.0
The role of 2′,3′-unsaturation on the antiviral activity of anti-HIV nucleosides against 3TC-resistant mutant (M184V)
Bioorganic &amp; Medicinal Chemistry Letters 2003.0
Synthesis and Anti-HIV Activity of <scp>d</scp>- and <scp>l</scp>-Thietanose Nucleosides
Journal of Medicinal Chemistry 2006.0
Synthesis and antiviral activity of monofluoro and difluoro analogs of pyrimidine deoxyribonucleosides against human immunodeficiency virus (HIV-1)
Journal of Medicinal Chemistry 1990.0